Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Open House Drug Discount Agreements For The Active Ingredient Tocilizumab, Atc L04ac07 2026-04-21
Germany Rivaroxaban (solid Oral Drf; Only For Hkk: Only Potency 2.5 Mg)_tk, Hek, Hkk 2026-04-21
Germany The Health Insurance Companies Aim To Conclude Discount Contracts According To § 130a Abs. 8 Sgb V With All Suitable Pharmaceutical Entrepreneurs For The Active Ingredients, Active Ingredient Combinations, Or Dosage Forms, Strengths, Or Finished Medicinal 2026-04-21
United Kingdom 703340450 - Procurement And In-service Support Of Man-portable Digital X Ray System 2026-04-21
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph. 8 Sgb V For The Active Ingredient Abiraterone (exclusively 500 Mg 90 Pieces), Atc L02bx03 For The Period December 1st, 2025 November 30th, 2027 2026-04-21
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130a Paragraph. 8 Sgb V On The Active Ingredients Mentioned With The Possibility Of Contracting Within The Framework Of The So-called Openhouse Procedure. 2026-04-21
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130a Paragraph. 8 Sgb V On The Active Ingredients Mentioned With The Possibility Of Contracting Within The Framework Of The So-called Openhouse Procedure. 2026-04-21
Germany Norethisteron/estradiol (atc: G03fa01, 0,88 Mg/2 Mg)_tk, Hek, Hkk 2026-04-21
United Kingdom 2022/27 Aqp Vasectomy Service On Behalf Of Nhs West Yorkshire Icb In Leeds 2026-04-21
Germany The Subject Of This Publication Is The Conclusion Of Contracts According To § 130a Abs. 8 Sgb V For Various Active Ingredients Within The Framework Of A So-called Open-house Procedure: Under The Provision Of Uniform Contractual Conditions And A Uniform Ac 2026-04-22
Whats app